Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer (Q34734131)

4 August 2017

1 reference

title

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer (English)

1 reference

4 August 2017

1 reference

1 reference

1 reference

Martin J Cannon

1

1 reference

4 August 2017

Timothy J O'Brien

2

1 reference

4 August 2017

L Joey Underwood

3

1 reference

4 August 2017

Mark D Crew

4

1 reference

4 August 2017

Kristina L Bondurant

5

1 reference

4 August 2017

Alessandro D Santin

6

1 reference

4 August 2017

1 February 2002

1 reference

Expert Review of Anticancer Therapy

4 August 2017

1 reference

4 August 2017

2

1 reference

4 August 2017

1

1 reference

4 August 2017

97-105

1 reference

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

4 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Dendritic cells as adjuvants for immune-mediated resistance to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Dendritic cell vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Dendritic cells: specialized and regulated antigen processing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Regulation of T cell immunity by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Dendritic cells as vectors for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Development and therapeutic effect of adoptively transferred T cells primed by tumor lysate-pulsed autologous dendritic cells in a patient with metastatic endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Induction of T cell responses against autologous ovarian tumors with whole tumor cell lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

The CA 125 gene: an extracellular superstructure dominated by repeat sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Ovarian tumor cells express a novel multi-domain cell surface serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.97

21 January 2018

Identifiers

DOI

10.1586/14737140.2.1.97

1 reference

4 August 2017

1 reference